Clinical TrialID 863

Arnica and the Management of Pain in Acute Musculoskeletal Extremity Injuries

NCT05283434

Pain, Muscle|Pain, Acute

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
863
Evidence Id
863
Core Evidence Id
863
Source Clinical Trial Id
845
Herb2 Clinical Trial Id
HBCT000845
Nct Id
NCT05283434
Title
Arnica and the Management of Pain in Acute Musculoskeletal Extremity Injuries
Status
Phase
Phase 2|Phase 3
Study Result
No
Study Condition
Pain, Muscle|Pain, Acute
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Intervention
DRUG: Arnica|DRUG: Placebo
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Triple
Intervention Purpose
Treatment
Gender
All
Age
Child, Adult
Enrollment
324
Outcome Measure
Ibuprofen Dose, Amount of Ibuprofen the patient consumed during the three full days after discharge, Initial Emergency Department Visit to three full days after discharge
Sponsor Collaborator
Children's Hospitals and Clinics of Minnesota
Funded By
OTHER
Location
Children's Minnesota, Minneapolis, Minnesota, 55404, United States|Children's Minnesota, Saint Paul, Minnesota, 55102, United States
Other Id
1812-139
Start Date
2021-07-15
Primary Completion Date
2023-06-30
Completion Date
2023-06-30
First Posted
2022-03-17
Results First Posted
Last Update Posted
2022-03-17
Study Document
Study Protocol, https://cdn.clinicaltrials.gov/large-docs/34/NCT05283434/Prot_000.pdf
Study Url
https://clinicaltrials.gov/study/NCT05283434
Title Cn
Title En
Arnica and the Management of Pain in Acute Musculoskeletal Extremity Injuries
Bilingual Status
semi_complete